Bosentan therapy in patients with pulmonary hypertension secondary to congenital heart disease (Eisenmenger physiology)

被引：1
|
作者：
D'Alto, M [1 ]
Sarubbi, B [1 ]
Vizza, CD [1 ]
Romeo, E [1 ]
Santoro, G [1 ]
Argiento, P [1 ]
Russo, MG [1 ]
Calabrò, R [1 ]
机构：
[1] Univ Naples 2, V Monaldi Hosp, Chair Cardiol, Naples, Italy
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
10.1378/chest.128.4_MeetingAbstracts.366S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：366S / 366S
页数：1
相关论文
共 50 条
  • [1] Pulmonary hypertension secondary to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical and haemodynamic impact of oral bosentan
    D'alto, M.
    Vizza, C. D.
    Sarubbi, B.
    Santoro, G.
    Badagliacca, R.
    Argiento, P.
    Poscia, R.
    Calabro, R.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 624 - 624
  • [2] Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology
    D'Alto, Michele
    Romeo, Emanuele
    Argiento, Paola
    Sarubbi, Berardo
    Santoro, Giuseppe
    Grimaldi, Nicola
    Correra, Anna
    Scognamiglio, Giancarlo
    Russo, Maria Giovanna
    Calabro, Raffaele
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 155 (03) : 378 - 382
  • [3] Safety and tolerability of bosentan in patients with pulmonary hypertension secondary to congenital heart disease
    D'Alto, M.
    Sarubbi, B.
    Romeo, E.
    Santoro, G.
    Santarpia, G.
    Argiento, P.
    Russo, M. G.
    Calabro, R.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 77 - 77
  • [4] EFFICACY AND SAFETY OF BOSENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION SECONDARY TO CONGENITAL HEART DISEASE
    Meng Lili
    Zhu Xianyang
    Zhang Duanzhen
    [J]. HEART, 2013, 99 : A42 - A42
  • [5] Bosentan-sildenafil association in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability and clinical effect
    Romeo, E.
    D'Alto, M.
    Argiento, P.
    Sarubbi, B.
    Santoro, G.
    Scognamiglio, G.
    Alfano, D.
    D'Alterio, G.
    Russo, M. G.
    Calabro', R.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 901 - 901
  • [6] Treatment of Patients with Severe Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease with Bosentan and Sildenafil
    Zhu, Xianyang
    Zhang, Duanzhen
    Meng, Jing
    Sheng, Xiaotang
    [J]. CIRCULATION, 2010, 122 (02) : E238 - E238
  • [7] Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology):: safety, tolerability, clinical, and haemodynamic effect
    D'Alto, M.
    Vizza, C. D.
    Romeo, E.
    Badagliacca, R.
    Santoro, G.
    Poscia, R.
    Sarubbi, B.
    Mancone, M.
    Argiento, P.
    Ferrante, F.
    Russo, M. G.
    Fedele, F.
    Calabro, R.
    [J]. HEART, 2007, 93 (05) : 621 - 625
  • [8] Pulmonary hypertension associated with congenital heart disease and Eisenmenger syndrome
    Calderon-Colmenero, Juan
    Sandoval Zarate, Julio
    Beltran Gamez, Miguel
    [J]. ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2015, 85 (01): : 32 - 49
  • [9] Pulmonary Hypertension in Congenital Heart Disease Beyond Eisenmenger Syndrome
    Krieger, Eric V.
    Leary, Peter J.
    Opotowsky, Alexander R.
    [J]. CARDIOLOGY CLINICS, 2015, 33 (04) : 599 - +
  • [10] Pulmonary arterial hypertension treatment with bosentan in pediatric patients with congenital heart disease
    Romero Jimenez, Rosa M.
    Garcia Sanchez, Raquel
    Gimenez Manzorro, Alvaro
    Martinez Fernandez-Llamazares, Cecilia
    Sanjurjo Saez, Maria
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 347 - 347
12345